Nye psykoaktive stoffer

Dorte Fris Palmqvist; Ragnar Thomsen; Brian Schou Rasmussen; Maha Said; Nanna Reiter

doi:10.61409/V10250795

Nye psykoaktive stoffer

Dorte Fris Palmqvist
, Ragnar Thomsen
, Brian Schou Rasmussen
, Maha Said
, Nanna Reiter

Abstract

New psychoactive substances (NPS) are substances not controlled by UN conventions and they pose a threat to public health. The number of NPS on the recreational market is increasing each year. NPS are classified into six categories based on pharmacological properties: sedatives, opioids, stimulants, hallucinogens, dissociatives and cannabinoids. NPS are easily accessible, vary in potency and composition, and many clinicians lack experience in treating intoxications with these compounds. Monitoring of NPS is essential to update legislation, reduce exposure and guide clinical practice, as argued in this review.

Bidragets oversatte titel	New psychoactive substances
Originalsprog	Dansk
Tidsskrift	Ugeskrift for Laeger
Vol/bind	188
Udgave nummer	21
ISSN	0041-5782
DOI	https://doi.org/10.61409/V10250795
Status	Udgivet - 18 maj 2026

Emneord

Humans
Psychotropic Drugs/pharmacology
Illicit Drugs/pharmacology
Hallucinogens/pharmacology
Cannabinoids/pharmacology
Central Nervous System Stimulants/pharmacology
Analgesics, Opioid/pharmacology
Substance-Related Disorders
Hypnotics and Sedatives/pharmacology
Designer Drugs/pharmacology

Adgang til dokumentet

10.61409/V10250795Licens: CC BY-NC-ND

Citationsformater

@article{431516c6778646f9967a646908da52b2,

title = "Nye psykoaktive stoffer",

abstract = "New psychoactive substances (NPS) are substances not controlled by UN conventions and they pose a threat to public health. The number of NPS on the recreational market is increasing each year. NPS are classified into six categories based on pharmacological properties: sedatives, opioids, stimulants, hallucinogens, dissociatives and cannabinoids. NPS are easily accessible, vary in potency and composition, and many clinicians lack experience in treating intoxications with these compounds. Monitoring of NPS is essential to update legislation, reduce exposure and guide clinical practice, as argued in this review.",

keywords = "Humans, Psychotropic Drugs/pharmacology, Illicit Drugs/pharmacology, Hallucinogens/pharmacology, Cannabinoids/pharmacology, Central Nervous System Stimulants/pharmacology, Analgesics, Opioid/pharmacology, Substance-Related Disorders, Hypnotics and Sedatives/pharmacology, Designer Drugs/pharmacology",

author = "Palmqvist, \{Dorte Fris\} and Ragnar Thomsen and Rasmussen, \{Brian Schou\} and Maha Said and Nanna Reiter",

note = "Published under Open Access CC-BY-NC-ND 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.",

year = "2026",

month = may,

day = "18",

doi = "10.61409/V10250795",

language = "Dansk",

volume = "188",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske L{\ae}geforening",

number = "21",

}

TY - JOUR

T1 - Nye psykoaktive stoffer

AU - Palmqvist, Dorte Fris

AU - Thomsen, Ragnar

AU - Rasmussen, Brian Schou

AU - Said, Maha

AU - Reiter, Nanna

N1 - Published under Open Access CC-BY-NC-ND 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.

PY - 2026/5/18

Y1 - 2026/5/18

N2 - New psychoactive substances (NPS) are substances not controlled by UN conventions and they pose a threat to public health. The number of NPS on the recreational market is increasing each year. NPS are classified into six categories based on pharmacological properties: sedatives, opioids, stimulants, hallucinogens, dissociatives and cannabinoids. NPS are easily accessible, vary in potency and composition, and many clinicians lack experience in treating intoxications with these compounds. Monitoring of NPS is essential to update legislation, reduce exposure and guide clinical practice, as argued in this review.

AB - New psychoactive substances (NPS) are substances not controlled by UN conventions and they pose a threat to public health. The number of NPS on the recreational market is increasing each year. NPS are classified into six categories based on pharmacological properties: sedatives, opioids, stimulants, hallucinogens, dissociatives and cannabinoids. NPS are easily accessible, vary in potency and composition, and many clinicians lack experience in treating intoxications with these compounds. Monitoring of NPS is essential to update legislation, reduce exposure and guide clinical practice, as argued in this review.

KW - Humans

KW - Psychotropic Drugs/pharmacology

KW - Illicit Drugs/pharmacology

KW - Hallucinogens/pharmacology

KW - Cannabinoids/pharmacology

KW - Central Nervous System Stimulants/pharmacology

KW - Analgesics, Opioid/pharmacology

KW - Substance-Related Disorders

KW - Hypnotics and Sedatives/pharmacology

KW - Designer Drugs/pharmacology

U2 - 10.61409/V10250795

DO - 10.61409/V10250795

M3 - Review

C2 - 42186883

SN - 0041-5782

VL - 188

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 21

ER -

Nye psykoaktive stoffer

Abstract

Emneord

Adgang til dokumentet

Fingeraftryk

Citationsformater